Showing results (4521-4530 of 25,889) with videos related to
Sort By:
Pageof 2,589
Anticancer Research|December 11, 2012
Review on the annual cancer risk of Barrett's esophagus in persons with symptoms of gastroesophageal reflux diseaseJohannes Lenglinger, Martin Riegler, Enrico Cosentini, et al.Anticancer Research|December 11, 2012
Bevacizumab plus docetaxel and cisplatin for metastatic breast cancer: a pilot phase II studyCheng-Jeng Tai, Ching-Shyang Chen, Chin-Sheng Hung, et al.Anticancer Research|December 11, 2012
Successful rechallenge for oxaliplatin hypersensitivity reactions in patients with metastatic colorectal cancerTakako Yanai, Satoru Iwasa, Hirhonobu Hashimoto, et al.Anticancer Research|May 18, 2012
Down-regulation of the epidermal growth factor receptor by altering N-glycosylation: emerging role of β1,4-galactosyltransferasesHans-J Gabius, Marlies van de Wouwer, Sabine André, et al.Anticancer Research|May 18, 2012
Acquisition of anoikis resistance up-regulates caveolin-1 expression in human non-small cell lung cancer cellsHasseri Halim, Sudjit Luanpitpong, Pithi ChanvorachoteAnticancer Research|May 18, 2012
The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2Dok Hyun Yoon, Jae-Sik Shin, Dong-Hoon Jin, et al.Anticancer Research|May 18, 2012
A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumorsBenjamin Friday, Yvonne Lassere, Christina A Meyers, et al.Anticancer Research|May 18, 2012
Classification of gastritis in first-degree relatives of patients with gastric cancer in a high cancer-risk area in ItalyCalogero Saieva, Carlos A Rubio, Gabriella Nesi, et al.Anticancer Research|May 18, 2012
Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancerTetsuhiro Goto, Kazuki Shinmura, Kazuaki Yokomizo, et al.Anticancer Research|May 18, 2012
T315I mutation in Ph-positive acute lymphoblastic leukemia is associated with a highly aggressive disease phenotype: three case reportsKeisuke Watanabe, Yosuke Minami, Yukiyasu Ozawa, et al.Pageof 2,589